Bausch + Lomb Corporation has grown revenue 11% a year over three years and 8.4% a year over five. Revenue growth, 3-year annual rate: +11% (Medical Instruments & Supplies median +9.8%). Revenue growth, 5-year rate: +8.4%, growth has picked up over the last three years. Years of annual history on file: 6, FY2020 to FY2025, as filed.

BLCOBausch + Lomb Corporation

Healthcare

$17.32+14% 1Y

$17.32

$14.3252 weeks$18.60

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin widening (+5.4 points).

1 good, 1 neutral, 1 without data

Revenue trend+9% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Margin direction+5.4 points operating

Trailing-twelve-month operating margin, 6.0% now against 0.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is BLCO growing?

Bausch + Lomb Corporation has grown revenue 11% a year over three years and 8.4% a year over five.

+11%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +9.8% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +8.4%
Revenue growth, 5-year rate · +11% over three · growth has picked up over the last three years
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›